| Year |
Citation |
Score |
| 2019 |
Zarski JP, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret MN, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P. Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clinics and Research in Hepatology and Gastroenterology. PMID 31839535 DOI: 10.1016/j.clinre.2019.11.005 |
0.306 |
|
| 2018 |
Ducancelle A, Leroy V, Vergniol J, Sturm N, Le Bail B, Zarski JP, Nguyen Khac E, Salmon D, de Ledinghen V, Calès P. A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases. Journal of Clinical Gastroenterology. 51: 639-649. PMID 28692443 DOI: 10.1097/MCG.0000000000000788 |
0.311 |
|
| 2016 |
Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, ... Zarski JP, et al. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology. PMID 27641509 DOI: 10.1053/J.Gastro.2016.09.009 |
0.454 |
|
| 2016 |
Marcellin P, Zoulim F, Hézode C, Causse X, Roche B, Truchi R, Pauwels A, Ouzan D, Dumortier J, Pageaux GP, Bourlière M, Riachi G, Zarski JP, Cadranel JF, Tilliet V, et al. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France. Digestive Diseases and Sciences. PMID 26821154 DOI: 10.1007/s10620-015-4027-8 |
0.322 |
|
| 2016 |
Ramzan M, Sturm N, Decaens T, Bioulac-Sage P, Bancel B, Merle P, Tran Van Nhieu J, Slama R, Letoublon C, Zarski JP, Jouvin-Marche E, Marche PN, Leroy V. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 434-44. PMID 26215124 DOI: 10.1111/liv.12927 |
0.305 |
|
| 2015 |
Stefas I, Tigrett S, Dubois G, Kaiser M, Lucarz E, Gobby D, Bray D, Ellerbrok H, Zarski JP, Veas F. Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus. Plos One. 10: e0140900. PMID 26502286 DOI: 10.1371/journal.pone.0140900 |
0.342 |
|
| 2015 |
Trinchet JC, Bourcier V, Chaffaut C, Ait Ahmed M, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, ... Zarski JP, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Hepatology (Baltimore, Md.). 62: 737-50. PMID 25678021 DOI: 10.1002/Hep.27743 |
0.405 |
|
| 2015 |
Bailly F, Virlogeux V, Dufour C, Pradat P, Hézode C, Larrey D, Alric L, Samuel D, Bourlière M, Métivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, et al. Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study. Clinics and Research in Hepatology and Gastroenterology. 39: 443-50. PMID 25636238 DOI: 10.1016/J.Clinre.2014.12.007 |
0.412 |
|
| 2015 |
Larrat S, Kulkarni O, Claude JB, Beugnot R, Blum MG, Fusillier K, Lupo J, Tremeaux P, Plages A, Marlu A, Duborjal H, Signori-Schmuck A, Francois O, Zarski JP, Morand P, et al. Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients. Journal of Clinical Microbiology. 53: 389-97. PMID 25411182 DOI: 10.1128/JCM.02547-14 |
0.323 |
|
| 2014 |
Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. The New England Journal of Medicine. 370: 1889-98. PMID 24725239 DOI: 10.1056/Nejmoa1402454 |
0.345 |
|
| 2014 |
Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, et al. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 147: 132-142.e4. PMID 24704719 DOI: 10.1053/J.Gastro.2014.03.051 |
0.385 |
|
| 2014 |
Leroy V, Sturm N, Faure P, Trocme C, Marlu A, Hilleret MN, Morel F, Zarski JP. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. Journal of Hepatology. 61: 28-34. PMID 24631902 DOI: 10.1016/j.jhep.2014.02.029 |
0.456 |
|
| 2014 |
Brakha C, Arvers P, Villiers F, Marlu A, Buhot A, Livache T, Calemczuk R, Zarski JP, Villiers CL, Marche PN, Villiers MB. Relationship between humoral response against hepatitis C virus and disease overcome. Springerplus. 3: 56. PMID 24516785 DOI: 10.1186/2193-1801-3-56 |
0.31 |
|
| 2014 |
Jouvin-Marche E, Macek JÃlková Z, Thelu MA, Marche H, Fugier E, Van Campenhout N, Hoang XS, Marlu A, Sturm N, Callanan M, Leroy V, Zarski JP, Marche PN. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. The Journal of Infectious Diseases. 209: 1907-15. PMID 24415789 DOI: 10.1093/infdis/jiu016 |
0.381 |
|
| 2014 |
Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, ... Zarski JP, et al. Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries. Journal of Viral Hepatitis. 21: 662-70. PMID 24329883 DOI: 10.1111/jvh.12202 |
0.313 |
|
| 2014 |
Boursier J, De Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C Journal of Gastroenterology. 49: 527-537. PMID 23681425 DOI: 10.1007/s00535-013-0819-9 |
0.347 |
|
| 2013 |
Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations. Clinics and Research in Hepatology and Gastroenterology. 37: 467-72. PMID 23932706 DOI: 10.1016/j.clinre.2013.07.003 |
0.39 |
|
| 2013 |
Zeuzem S, Asselah T, Angus P, Zarski JP, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse AW, Pol S, Bronowicki JP, Roberts S, Arasteh K, Zoulim F, Heim M, et al. Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results. Antiviral Therapy. 18: 1015-9. PMID 23558093 DOI: 10.3851/IMP2567 |
0.302 |
|
| 2013 |
Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. Plos One. 8: e59088. PMID 23555619 DOI: 10.1371/journal.pone.0059088 |
0.337 |
|
| 2013 |
Sturm N, Marlu A, Arvers P, Zarski JP, Leroy V. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C. Liver International : Official Journal of the International Association For the Study of the Liver. 33: 428-38. PMID 23402612 DOI: 10.1111/liv.12092 |
0.428 |
|
| 2013 |
Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. Clinica Chimica Acta; International Journal of Clinical Chemistry. 415: 63-8. PMID 23022619 DOI: 10.1016/j.cca.2012.09.020 |
0.312 |
|
| 2012 |
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Lenaour G, Vaillant JC, Ratziu V, Charlotte F. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology. 36: 455-63. PMID 22959098 DOI: 10.1016/j.clinre.2012.08.002 |
0.373 |
|
| 2012 |
Larrat S, Bourdon C, Baccard M, Garnaud C, Mathieu S, Quesada JL, Signori-Schmuck A, Germi R, Blanc M, Leclercq P, Hilleret MN, Leroy V, Zarski JP, Morand P. Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture Journal of Clinical Virology. 55: 220-225. PMID 22901327 DOI: 10.1016/j.jcv.2012.07.016 |
0.408 |
|
| 2012 |
Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C. Clinical Chemistry and Laboratory Medicine. 50: 693-9. PMID 22505560 DOI: 10.1515/cclm-2011-0858 |
0.314 |
|
| 2012 |
Larrey D, Lohse AW, de Ledinghen V, Trepo C, Gerlach T, Zarski JP, Tran A, Mathurin P, Thimme R, Arastéh K, Trautwein C, Cerny A, Dikopoulos N, Schuchmann M, Heim MH, et al. Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. Journal of Hepatology. 57: 39-46. PMID 22414766 DOI: 10.1016/j.jhep.2012.02.015 |
0.34 |
|
| 2012 |
Zeuzem S, Buggisch P, Agarwal K, Marcellin P, Sereni D, Klinker H, Moreno C, Zarski JP, Horsmans Y, Mo H, Arterburn S, Knox S, Oldach D, McHutchison JG, Manns MP, et al. The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology (Baltimore, Md.). 55: 749-58. PMID 22006408 DOI: 10.1002/hep.24744 |
0.325 |
|
| 2012 |
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Le Naour G, Vaillant JC, Ratziu V, Charlotte F. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. Journal of Hepatology. 56: 541-8. PMID 21889468 DOI: 10.1016/j.jhep.2011.08.007 |
0.351 |
|
| 2012 |
Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. Journal of Hepatology. 56: 55-62. PMID 21781944 DOI: 10.1016/j.jhep.2011.05.024 |
0.369 |
|
| 2012 |
Marcellin P, Zoulim F, Causse X, Hézode C, Larrey D, Pageaux G, Roche B, Truchi R, Ouzan D, Pauwels A, Dumortier J, Stern C, Libert O, Cadranel J, Zarski J. 531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE Journal of Hepatology. 56: S210. DOI: 10.1016/S0168-8278(12)60544-3 |
0.393 |
|
| 2012 |
Marcellin P, Zoulim F, Causse X, Hézode C, Larrey D, Pageaux G, Roche B, Truchi R, Ouzan D, Pauwels A, Dumortier J, Stern C, Libert O, Cadranel J, Zarski J. 530 HIGH EFFICACY AND SAFETY OF TENOFOVIR DF IN 441 NAIVE AND NUC-EXPERIENCED CHRONIC HEPATITIS B PATIENTS: A REAL LIFE MULTICENTER PROSPECTIVE COHORT STUDY Journal of Hepatology. 56: S210. DOI: 10.1016/S0168-8278(12)60543-1 |
0.344 |
|
| 2011 |
Zeuzem S, Asselah T, Angus P, Zarski JP, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse A, Pol S, Bronowicki JP, Roberts S, Arasteh K, Zoulim F, Heim M, et al. Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection. Gastroenterology. 141: 2047-55; quiz e14. PMID 21925126 DOI: 10.1053/j.gastro.2011.08.051 |
0.345 |
|
| 2011 |
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Moussalli J, Lebray P, Thabut D, Ratziu V. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clinics and Research in Hepatology and Gastroenterology. 35: 720-30. PMID 21852224 DOI: 10.1016/j.clinre.2011.07.003 |
0.375 |
|
| 2011 |
Habersetzer F, Honnet G, Bain C, Maynard-Muet M, Leroy V, Zarski JP, Feray C, Baumert TF, Bronowicki JP, Doffoël M, Trépo C, Agathon D, Toh ML, Baudin M, Bonnefoy JY, et al. A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C. Gastroenterology. 141: 890-899.e1-4. PMID 21699798 DOI: 10.1053/j.gastro.2011.06.009 |
0.344 |
|
| 2011 |
Boursier J, de Ledinghen V, Zarski JP, Rousselet MC, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, Oberti F, Dib N, Calès P. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. The American Journal of Gastroenterology. 106: 1255-63. PMID 21468012 DOI: 10.1038/ajg.2011.100 |
0.304 |
|
| 2011 |
Zarski JP. [Natural history of viral hepatitis]. La Revue Du Praticien. 61: 33-8. PMID 21452540 |
0.414 |
|
| 2010 |
Zarski JP. [Influence of treatment on long-term evolution of chronic hepatitis B]. GastroentéRologie Clinique Et Biologique. 34: S109-11. PMID 21095513 DOI: 10.1016/S0399-8320(10)70029-4 |
0.377 |
|
| 2010 |
Marcellin P, Cadranel JF, Fontanges T, Poynard T, Pol S, Trepo C, Blin P, Bregman B, Schmidely N, Roudot-Thoraval F, Zarski JP. High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients. European Journal of Gastroenterology & Hepatology. 22: 1290-6. PMID 20964259 DOI: 10.1097/MEG.0b013e32832fba4f |
0.366 |
|
| 2010 |
Zarski JP, Sturm N, Desmorat H, Melin P, Raabe JJ, Bonny C, Sogni P, Pinta A, Rouanet S, Babany G, Cheveau A, Chevallier M. Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study. Liver International : Official Journal of the International Association For the Study of the Liver. 30: 1049-58. PMID 20492512 DOI: 10.1111/j.1478-3231.2010.02265.x |
0.379 |
|
| 2010 |
Sturm N, Thélu MA, Camous X, Dimitrov G, Ramzan M, Dufeu-Duchesne T, Bonorino P, Guillermet C, Brambilla E, Arvers P, Pernollet M, Leroy V, Zarski JP, Marche PN, Jouvin-Marche E. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. Journal of Hepatology. 53: 25-35. PMID 20452085 DOI: 10.1016/j.jhep.2010.02.024 |
0.337 |
|
| 2010 |
Levast M, Larrat S, Thelu MA, Nicod S, Plages A, Cheveau A, Zarski JP, Seigneurin JM, Morand P, Leroy V. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. Journal of Medical Virology. 82: 747-54. PMID 20336715 DOI: 10.1002/Jmv.21695 |
0.626 |
|
| 2010 |
Guéchot J, Lasnier E, Sturm N, Paris A, Zarski JP. Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort. Clinica Chimica Acta; International Journal of Clinical Chemistry. 411: 86-91. PMID 19850017 DOI: 10.1016/j.cca.2009.10.011 |
0.402 |
|
| 2009 |
Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. Journal of Hepatology. 51: 458-67. PMID 19596474 DOI: 10.1016/j.jhep.2009.05.030 |
0.353 |
|
| 2009 |
Zarski JP. [Clinical case: treatment of chronic hepatitis B]. GastroentéRologie Clinique Et Biologique. 33: 358-60. PMID 19345534 DOI: 10.1016/j.gcb.2009.02.016 |
0.364 |
|
| 2009 |
Zarski JP. [New molecules in the treatment of chronic hepatitis B]. Presse MéDicale (Paris, France : 1983). 38: 692-4. PMID 19233605 DOI: 10.1016/j.lpm.2009.01.007 |
0.352 |
|
| 2009 |
Lupo J, Larrat S, Hilleret MN, Germi R, Boyer V, Nicod S, Barguès G, Leroy V, Seigneurin JM, Zarski JP, Morand P. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays. Journal of Virological Methods. 156: 52-8. PMID 19041345 DOI: 10.1016/j.jviromet.2008.10.028 |
0.581 |
|
| 2009 |
Zoulim F, Parvaz P, Marcellin P, Zarski JP, Beaugrand M, Benhamou Y, Bailly F, Maynard M, Trepo C, Trylesinski A, Monchecourt F. Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure. Liver International : Official Journal of the International Association For the Study of the Liver. 29: 420-6. PMID 18795900 DOI: 10.1111/j.1478-3231.2008.01867.x |
0.328 |
|
| 2008 |
Zarski JP, Leroy V. [The patient with uncontrolled chronic hepatitis B]. GastroentéRologie Clinique Et Biologique. 32: S7-11. PMID 18662613 DOI: 10.1016/S0399-8320(08)73259-7 |
0.464 |
|
| 2008 |
Larrat S, Hilleret MN, Germi R, Lupo J, Nicod S, Zarski JP, Seigneurin JM, Morand P. Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs. Comparative Hepatology. 7: 3. PMID 18336716 DOI: 10.1186/1476-5926-7-3 |
0.585 |
|
| 2008 |
Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, Antona D, Bovet M, Mechain M, Asselah T, Desenclos JC, Jougla E. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. Journal of Hepatology. 48: 200-7. PMID 18086507 DOI: 10.1016/j.jhep.2007.09.010 |
0.369 |
|
| 2008 |
Leroy V, Sturm N, Trocme C, Hilleret M, Faure P, Renversez J, Morel F, Zarski J. 661 DIAGNOSTIC PERFORMANCE OF NON-INVASIVE SCORES FOR THE DIAGNOSIS OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Journal of Hepatology. 48: S246-S247. DOI: 10.1016/S0168-8278(08)60663-7 |
0.36 |
|
| 2007 |
Zarski JP, Bedossa P, Bronowicki JP, Doffoel M, Poynard T. [Non invasive markers using for the assessment of fibrosis in hepatitis C]. GastroentéRologie Clinique Et Biologique. 31: 4S34-9. PMID 17965633 DOI: GCB-09-2007-31-9-C3-0399-8320-101019-200600494 |
0.316 |
|
| 2007 |
Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, Castera L, De Ledinghen V, Marcellin P, Poupon R, Bourlière M, Zarski JP, Roudot-Thoraval F, Bresson-Hadni S, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection Journal of Viral Hepatitis. 14: 460-467. PMID 17576387 DOI: 10.1111/j.1365-2893.2006.00823.x |
0.323 |
|
| 2007 |
Roblin X, Pofelski J, Zarski JP. [Steatosis, chronic hepatitis virus C infection and homocysteine]. GastroentéRologie Clinique Et Biologique. 31: 415-20. PMID 17483780 DOI: 10.1016/S0399-8320(07)89402-4 |
0.403 |
|
| 2007 |
Roblin X, Genevois M, Ducros V, Zarski JP, Leroy V. Biermer's anemia: a new cause of cholestasis and hepatic steatosis? Digestive Diseases and Sciences. 52: 3366-8. PMID 17436084 DOI: 10.1007/s10620-007-9761-0 |
0.323 |
|
| 2007 |
Thélu MA, Leroy V, Ramzan M, Dufeu-Duchesne T, Marche P, Zarski JP. IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients. Journal of Medical Virology. 79: 242-53. PMID 17245718 DOI: 10.1002/jmv.20792 |
0.364 |
|
| 2007 |
Roblin X, Ducros V, Hilleret M, Sturm N, Plages A, Zarski J, Leroy V. [551] HYPERHOMOCYSTEINEMIA IN CHRONIC HEPATITIS C: ROLE IN STEATOSIS, FIBROGENESIS AND RESPONSE TO ANTIVIRAL TREATMENT Journal of Hepatology. 46: S209-S210. DOI: 10.1016/S0168-8278(07)62149-7 |
0.389 |
|
| 2007 |
Marcellin P, Cadranel J, Fontanges T, Poynard T, Pol S, Trepo C, Blin P, Bregman B, Mariot P, Roudot-Thoraval F, Zarski J. [509] WHICH PATIENTS WITH CHRONIC HEPATITIS B ARE TREATED AND HOW: A CROSS-SECTIONAL STUDY IN FRANCE ON 1790 PATIENTS Journal of Hepatology. 46: S194. DOI: 10.1016/S0168-8278(07)62107-2 |
0.334 |
|
| 2006 |
Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, et al. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology. 131: 1040-8. PMID 17030174 DOI: 10.1053/j.gastro.2006.07.022 |
0.419 |
|
| 2006 |
Bonny C, Fontaine H, Poynard T, Hézode C, Larrey D, Marcellin P, Bourlière M, Bronowicki JP, Merle P, Zarski JP, Sapey T, Guillemard C, Ughetto S, Henquell C, Nicolas C, et al. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study. Alimentary Pharmacology & Therapeutics. 24: 593-600. PMID 16907892 DOI: 10.1111/j.1365-2036.2006.03018.x |
0.432 |
|
| 2006 |
Zarski JP, Marcellin P, Leroy V, Trepo C, Samuel D, Ganne-Carrie N, Barange K, Canva V, Doffoel M, Cales P. Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases. Journal of Hepatology. 45: 355-60. PMID 16750585 DOI: 10.1016/j.jhep.2006.03.007 |
0.408 |
|
| 2006 |
Zarski JP. [Epidemiology of chronic hepatitis B]. Presse MéDicale (Paris, France : 1983). 35: 304-7. PMID 16493334 |
0.452 |
|
| 2006 |
Hilleret M, Faure E, Trocme C, Sturm N, Renversez J, Morel E, Zarski J, Leroy V. 462 Diagnostic accuracy of MP3 score compared to hyaluronate and fibrotest for evaluating liver fibrosis in chronic hepatitis B Journal of Hepatology. 44: S172. DOI: 10.1016/S0168-8278(06)80462-9 |
0.383 |
|
| 2005 |
Fafi-Kremer S, Zarski JP. [What tests should be prescribed in HBs-positive patients]. GastroentéRologie Clinique Et Biologique. 29: 364-8. PMID 15864196 |
0.448 |
|
| 2004 |
Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, Morel F, Zarski JP. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. The American Journal of Gastroenterology. 99: 271-9. PMID 15046217 DOI: 10.1111/j.1572-0241.2004.04055.x |
0.394 |
|
| 2004 |
Thelu MA, Drouet E, Hilleret MN, Zarski JP. Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus. Journal of Medical Virology. 72: 396-405. PMID 14748063 DOI: 10.1002/jmv.20021 |
0.38 |
|
| 2003 |
Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP, Marche PN, Jouvin-Marche E. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology (Baltimore, Md.). 38: 829-41. PMID 14512870 DOI: 10.1002/Hep.1840380409 |
0.369 |
|
| 2001 |
Germi R, Crance JM, Garin D, Zarski JP, Drouet E. Systems for hepatitis C virus culture Pathologie Biologie. 49: 255-261. PMID 11367561 DOI: 10.1016/S0369-8114(01)00137-7 |
0.32 |
|
| 2001 |
Leroy V, Dutertre N, Tran A, Naveau S, Abergel A, Bronwicki J, Bourliere M, Plages A, Roman V, Zarski J. High-daily induction dose of interferon in combination with ribavirin in chronic hepatitis C (CHC) non responder patients: a randomised controlled trial Journal of Hepatology. 34: 146. DOI: 10.1016/S0168-8278(01)81407-0 |
0.335 |
|
| 2001 |
Germi R, Crance J, Garin D, Guimet J, Rothlisberger C, Zarski J, Drouet E. Real time RT-PCR quantification: a new method to study hepatitis C virus adsorption on vero cells Journal of Hepatology. 34: 117. DOI: 10.1016/S0168-8278(01)81298-8 |
0.315 |
|
| 1994 |
Bichard P, Ounanian A, Girard M, Baccard C, Rolachon A, Renversez JC, Cordonnier D, Seigneurin JM, Debru JL, Zarski JP. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. Journal of Hepatology. 21: 58-63. PMID 7525697 DOI: 10.1016/S0168-8278(94)80137-1 |
0.583 |
|
| 1990 |
Causse X, Godinot H, Zbulim F, Chossegros P, Fontanges T, Zarski J, Meschievitz C, Albrecht J, Trépo C. Remarkable improvement of chronic hepatitis B following simultaneous administration of interferon and short term prednisone therapy Journal of Hepatology. 11: S16. DOI: 10.1016/0168-8278(90)91400-Q |
0.328 |
|
| Show low-probability matches. |